GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » International Biotechnology Trust PLC (LSE:IBT) » Definitions » 3-Year EPS without NRI Growth Rate

International Biotechnology Trust (LSE:IBT) 3-Year EPS without NRI Growth Rate : -50.50% (As of Feb. 2024)


View and export this data going back to 1994. Start your Free Trial

What is International Biotechnology Trust 3-Year EPS without NRI Growth Rate?

International Biotechnology Trust's EPS without NRI for the six months ended in Feb. 2024 was £0.73.

During the past 12 months, International Biotechnology Trust's average EPS without NRI Growth Rate was -54.10% per year. During the past 3 years, the average EPS without NRI Growth Rate was -50.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of International Biotechnology Trust was 261.50% per year. The lowest was -150.70% per year. And the median was -0.40% per year.


Competitive Comparison of International Biotechnology Trust's 3-Year EPS without NRI Growth Rate

For the Asset Management subindustry, International Biotechnology Trust's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


International Biotechnology Trust's 3-Year EPS without NRI Growth Rate Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, International Biotechnology Trust's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where International Biotechnology Trust's 3-Year EPS without NRI Growth Rate falls into.



International Biotechnology Trust 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


International Biotechnology Trust  (LSE:IBT) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


International Biotechnology Trust 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of International Biotechnology Trust's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


International Biotechnology Trust (LSE:IBT) Business Description

Traded in Other Exchanges
Address
65 Gresham Street, 6th Floor, London, GBR, EC2V 7NQ
International Biotechnology Trust PLC is an investment trust company. It aims at achieving long-term capital growth by investing in biotechnology and other life sciences companies. It seeks to achieve its objective by investing in a diversified portfolio of companies which has good growth prospects. It focuses on investments in biotechnology companies which are engaged in on drug discovery and development, medical devices companies and healthcare services provider. The invests in various financial instruments such as equities, index-linked securities, debt securities, cash deposits, money market instruments and foreign currency exchange transactions. Its revenue comprises of dividend, interest and other income from investment made.

International Biotechnology Trust (LSE:IBT) Headlines

No Headlines